AERX ULTRA

Aradigm Corporation

Application Filed: 2002-01-17

Trademark Application Details

Mark For: AERX ULTRA® trademark registration is intended to cover the categories of pharmaceutical preparations, namely analgesics, hormones, psychotropics, anti-infectives, anti-inflammatories, and anti-cancer agents for use in the treatment of disease via application to the lungs. [all]

Status

2022-08-05 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	76360151
Registration Number	2843548
Mark Literal Elements	AERX ULTRA
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	FILE REPOSITORY (FRANCONIA) 2004-06-03
Basis	1(a)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Attorney Name	Michelle D. Kahn
Attorney Docket Number	37W-84959
Law Office Assigned	M60
Employee Name	SOUDERS, MICHAEL J

Timeline

2002-01-17	Application Filed
2002-09-00	Date of First Use
2002-09-01	Date of First Use
2002-09-01	Date of Use In Commerce
2002-09-24	Published
2002-09-24	Published for Opposition
2004-05-18	Trademark Registered
2004-06-03	Location: FILE REPOSITORY (FRANCONIA)
2010-12-24	Cancelled
2010-12-24	Status: Dead/Cancelled
2010-12-24	Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	Aradigm Corporation
Address	3929 Point Eden Way Hayward, CALIFORNIA UNITED STATES 94545
Legal Entity Type	Corporation
Legal Entity State	CALIFORNIA

Documents

Application	IMAGE/TIFF	2002-01-17
Drawing	IMAGE/TIFF	2002-01-17
Duplicate Application		2002-01-17
Duplicate Drawing		2002-01-17
XSearch Search Summary		2002-04-12
XSearch Search Summary		2002-04-12
Offc Action Outgoing		2002-04-17
Paper Correspondence Incoming		2002-05-14
Response to Office Action		2002-05-14
Unclassified-Other		2002-06-13
Evidence		2002-08-11
Notice of Allowance		2002-12-17
Paper Correspondence Incoming		2003-06-18
Statement of Use		2003-06-18
File Jacket		2003-08-08
Specimen		2003-08-08
Offc Action Outgoing		2003-08-14
Paper Correspondence Incoming		2004-02-17
Notice of Acceptance of Statement of Use		2004-04-06
Registration Certificate		2004-05-18

Attorney of Record

MICHELLE D. KAHN
SHEPPARD, MULLIN, RICHTER & HAMPTON LLP
FOUR EMBARCADERO CENTER
SEVENTEENTH FLOOR
SAN FRANCISCO, CA 94111-4106

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations, namely analgesics, hormones, psychotropics, anti-infectives, anti-inflammatories, and anti-cancer agents for use in the treatment of disease via application to the lungs. FIRST USE: 20020900. FIRST USE IN COMMERCE: 20020900(CANCELLED)
IC 010. US 026 039 044. G & S: Medical apparatus, namely, electronically-based devices used to deliver drugs and biologics to the lungs. FIRST USE: 20020900. FIRST USE IN COMMERCE: 20020900

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	10
U.S. Codes:	026,039,044

Type Code	Type
GS0051	Pharmaceutical preparations, namely analgesics, hormones, psychotropics, anti-infectives, anti-inflammatories, and anti-cancer agents for use in the treatment of disease via application to the lungs

Trademark Filing History

Description	Date	Proceeding Number
CANCELLED SEC. 8 (6-YR)	2010-12-24
REGISTERED-PRINCIPAL REGISTER	2004-05-18
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	2004-03-12
PAPER RECEIVED	2004-02-17
CORRESPONDENCE RECEIVED IN LAW OFFICE	2004-02-17
NON-FINAL ACTION MAILED	2003-08-15
ASSIGNED TO EXAMINER	2003-08-12	76596
CASE FILE IN TICRS	2003-08-11
STATEMENT OF USE PROCESSING COMPLETE	2003-07-30
PAPER RECEIVED	2003-06-18
USE AMENDMENT FILED	2003-06-16
NOA MAILED - SOU REQUIRED FROM APPLICANT	2002-12-17
PUBLISHED FOR OPPOSITION	2002-09-24
NOTICE OF PUBLICATION	2002-09-04
APPROVED FOR PUB - PRINCIPAL REGISTER	2002-06-24
PAPER RECEIVED	2002-05-14
CORRESPONDENCE RECEIVED IN LAW OFFICE	2002-05-14
NON-FINAL ACTION MAILED	2002-04-17
ASSIGNED TO EXAMINER	2002-04-11	76596
ASSIGNED TO EXAMINER	2002-04-04	65999

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.